AdaptHealth Corp. reported its third-quarter financial results today, revealing a 10.9% increase in net revenue compared to the same period last year. Despite this growth, the company faced a significant net loss largely due to a $184.8 million pre-tax write-down of goodwill. These results are crucial as they highlight the company's ongoing adjustments in the competitive home health care services industry.

AdaptHealth Corp., based in Conshohocken, Pennsylvania, operates under the SIC classification of 8082, which covers home health care services. The company trades on the Nasdaq under the ticker symbol AHCO. Recent filings indicate that AdaptHealth is a large accelerated filer, reflecting its significant market presence.

According to the filing dated November 3, 2026, AdaptHealth's net revenue for the third quarter was $745.6 million, up from $672.4 million in the previous year. The company also reported organic revenue growth of 12.8%, with gains across all reportable segments. However, net loss attributable to AdaptHealth was $168.2 million, a stark contrast to the net income of $10.2 million reported in the same quarter last year.

Management noted that the financial results were impacted by a goodwill write-down, which significantly affected the bottom line. Adjusted EBITDA was reported at $141.9 million, a slight decrease from $146.1 million in the previous year. Cash flow from operations was $395.6 million year-to-date, down from $418.6 million during the same period in 2025.

AdaptHealth's recent performance may affect various stakeholders, including investors, employees, and healthcare partners. The company's strategic moves, such as its capitated agreement with a national integrated delivery network, are aimed at improving profitability and efficiency. The filing also noted that the company cleared the Hart-Scott-Rodino waiting period for the pending sale of its Diabetes Health business for $235 million, which is expected to close in early 2027.

Looking ahead, AdaptHealth is focusing on expanding its partnerships and enhancing its service offerings. The filing does not specify what happens next, but the ongoing developments in the home health care sector will likely shape the company's future strategies and market positioning.